2009•Unpublished venueRequires access

clinical study of three dimensional conformal radiotherapy combined with chemotherapy for recurrent esophageal carcinoma after radical radiotherapy

Ying Zhao

Open publisher page 0 citations

Abstract

Objective:To investigate the effects of three dimensional conformal radiotherapy(3-DCRT) combined with chemotherapy in recurrent esophageal carcinoma after radical radiotherapy.Methods:Total of 38 patients were given 3-DCRT combined with chemotherapy.Results:The overall response rate was 89.4%,60.5% with CR,28.9% with PR,SD 5.3%,PD 5.3%,1,2 year survival rates were 60.5%,34.2% respectively.Conclusion:In patients with recurrent esophageal carcinoma after radical radiotherapy,3-DCRT combined with chemotherapy can improve local control,and increase survival rate.

About this research paper

What this paper is about

Objective:To investigate the effects of three dimensional conformal radiotherapy(3-DCRT) combined with chemotherapy in recurrent esophageal carcinoma after radical radiotherapy.Methods:Total of 38 patients were given 3-DCRT combined with chemotherapy.Results:The overall response rate was 89.4%,60.5% with CR,28.9% with PR,SD 5.3%,PD 5.3%,1,2 year survival rates were 60.5%,34.2% respectively.Conclusion:In patients with recurrent esophageal carcinoma after radical radiotherapy,3-DCRT combined with chemotherapy can improve local control,and increase survival rate.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the effects of three dimensional conformal radiotherapy(3-DCRT) combined with chemotherapy in recurrent esophageal carcinoma after radical radiotherapy.Methods:Total of 38 patients were given 3-DCRT combined with chemotherapy.Results:The overall response rate was 89.4%,60.5% with CR,28.9% with PR,SD 5.3%,PD 5.3%,1,2 year survival rates were 60.5%,34.2% respectively.Conclusion:In patients with recurrent esophageal carcinoma after radical radiotherapy,3-DCRT combined with chemotherapy can improve local control,and increase survival rate.

Key concepts: Medicine, Radiation therapy, Chemotherapy, Carcinoma, Survival rate, Oncology, Internal medicine, Radiology

Related papers

Back to paper searchBrowse research topicsOriginal source
clinical study of three dimensional conformal radiotherapy combined with chemotherapy for recurrent esophageal carcinoma after radical radiotherapy — Research Paper | ScholarLens